READ OUR 2025 REPORT TO READERS

Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

102.52 +0.78 (+0.77%)
Streaming Delayed Price Updated: 3:06 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
News headline image
With Expenses Growing Faster Than Revenue, Is This Cathie Wood Stock in Trouble? ↗
Guardant Health released earnings earlier this month, disappointing investors with its sluggish revenue growth and increasing expenses. 
Via The Motley Fool
News headline image
Guardant360® CDx Receives FDA Approval as Companion Diagnostic for Janssen’s RYBREVANT™ (amivantamab-vmjw) for Use in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
From Guardant Health, Inc.
Via Business Wire
News headline image
Why Exact Sciences Stock Soared Today ↗
The company's Cologuard DNA test appears to be in good shape to maintain its market leadership. 
Via The Motley Fool
News headline image
Guardant Had Colon Cancer Data, But Rival Exact Popped — Here's Why ↗
Guardant and Exact are in a "win-win situation," an analyst said Thursday as EXAS stock surged on a comparison to Guardant in colon cancer detection. 
Via Investor's Business Daily
News headline image
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
News headline image
Guardant Health to Participate in Upcoming June Investor Conferences
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health Presents Data at 2021 ASCO Annual Meeting Showing Utility of Liquid Biopsy in Early- and Late-Stage Cancers
From Guardant Health, Inc.
Via Business Wire
News headline image
Exact Sciences' First-Quarter Results Show Its Strength Under Pressure ↗
Despite ongoing pandemic-related headwinds, the medical diagnostic test maker's revenue grew. So how will it perform as those headwinds dissipate? 
Via The Motley Fool
News headline image
3 Cathie Wood Stocks for a $150 Billion Market That's Just Forming ↗
Falling costs are ushering in a new era of screening for a dreaded disease. 
Via The Motley Fool
News headline image
What 7 Analyst Ratings Have To Say About Guardant Health ↗
Guardant Health (NASDAQ:GH) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 1 0 0 1... 
Via Benzinga
News headline image
Guardant Health Inc (GH) Q1 2021 Earnings Call Transcript ↗
GH earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers T2 Biosystems (NASDAQ:TTOO) share... 
Via Benzinga
News headline image
Guardant Health Reports First Quarter 2021 Financial Results
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health Appoints Craig Eagle, MD as Chief Medical Officer
From Guardant Health, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
Study Shows Guardant Reveal™ Blood-Only Liquid Biopsy Test Predicts Risk for Colorectal Cancer Recurrence with Industry-Leading Sensitivity
From Guardant Health
Via Business Wire
News headline image
Guardant Health to Participate in the BofA Securities 2021 Healthcare Conference
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health Announces Collaboration With Daiichi Sankyo to Develop Guardant360® CDx as a Companion Diagnostic for Enhertu® in Advanced Metastatic Non-Small Cell Lung Cancer
From Guardant Health, Inc.
Via Business Wire
News headline image
Disruptor Alert: These 2 Companies Are Changing Cancer Care ↗
Their liquid biopsies are giving doctors new and better tools to spot, track, and treat cancers. 
Via The Motley Fool
News headline image
Guardant Health to Report First Quarter Financial Results on May 6, 2021
From Guardant Health, Inc.
Via Business Wire
News headline image
Data at AACR Demonstrate Growing Clinical Utility of Guardant Health Liquid Biopsies in the Treatment and Management of Advanced Cancers
From Guardant Health, Inc.
Via Business Wire
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Gift this article